Literature DB >> 10821677

Human CC chemokine I-309, structural consequences of the additional disulfide bond.

D W Keizer1, M P Crump, T W Lee, C M Slupsky, I Clark-Lewis, B D Sykes.   

Abstract

I-309 is a member of the CC subclass of chemokines and is one of only three human chemokines known to contain an additional, third disulfide bond. The three-dimensional solution structure of I-309 was determined by (1)H nuclear magnetic resonance spectroscopy and dynamic simulated annealing. The structure of I-309, which remains monomeric at high concentrations, was determined on the basis of 978 experimental restraints. The N-terminal region of I-309 was disordered, as has been previously observed for the CC chemokine eotaxin but not others such as MCP-1 and RANTES. This was followed in I-309 by a well-ordered region between residues 13 and 69 that consisted of a 3(10)-helix, a triple-stranded antiparallel beta-sheet, and finally a C-terminal alpha-helix. Root-mean-square deviations of 0.61 and 1.16 were observed for the backbone and heavy atoms, respectively. A comparison of I-309 to eotaxin and HCC-2 revealed a significant structural change in the C-terminal region of the protein. The alpha-helix normally present in chemokines was terminated early and was followed by a short section of extended strand. These changes were a direct result of the additional disulfide bond present in this protein. An examination of the I-309 structure will aid in an understanding of the specificity of this protein with its receptor, CCR8.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10821677     DOI: 10.1021/bi000089l

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Structure-function analysis of CCL28 in the development of post-viral asthma.

Authors:  Monica A Thomas; Becky J Buelow; Amanda M Nevins; Stephanie E Jones; Francis C Peterson; Rebekah L Gundry; Mitchell H Grayson; Brian F Volkman
Journal:  J Biol Chem       Date:  2015-01-02       Impact factor: 5.157

2.  The Solution Structure of CCL28 Reveals Structural Lability that Does Not Constrain Antifungal Activity.

Authors:  Monica A Thomas; Jie He; Francis C Peterson; Anna R Huppler; Brian F Volkman
Journal:  J Mol Biol       Date:  2018-06-15       Impact factor: 5.469

3.  Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines.

Authors:  Amanda E I Proudfoot; Tracy M Handel; Zoë Johnson; Elaine K Lau; Patricia LiWang; Ian Clark-Lewis; Frédéric Borlat; Timothy N C Wells; Marie H Kosco-Vilbois
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-05       Impact factor: 11.205

Review 4.  Chemokine oligomerization in cell signaling and migration.

Authors:  Xu Wang; Joshua S Sharp; Tracy M Handel; James H Prestegard
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

5.  Human macrophage inflammatory protein 3alpha: protein and peptide nuclear magnetic resonance solution structures, dimerization, dynamics, and anti-infective properties.

Authors:  David I Chan; Howard N Hunter; Brian F Tack; Hans J Vogel
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

6.  Structural perspectives on antimicrobial chemokines.

Authors:  Leonard T Nguyen; Hans J Vogel
Journal:  Front Immunol       Date:  2012-12-28       Impact factor: 7.561

7.  C-terminal clipping of chemokine CCL1/I-309 enhances CCR8-mediated intracellular calcium release and anti-apoptotic activity.

Authors:  Catherine Denis; Kathleen Deiteren; Anneleen Mortier; Amel Tounsi; Erik Fransen; Paul Proost; Jean-Christophe Renauld; Anne-Marie Lambeir
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

8.  Human antimicrobial peptides and proteins.

Authors:  Guangshun Wang
Journal:  Pharmaceuticals (Basel)       Date:  2014-05-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.